Life Sciences

Three ways to run a more efficient drug trial

Written by Watson Health | Data, Life Sciences

Focusing on drug trial efficiency can go a long way towards cutting costs and reducing the impact of trial failures and delays on the bottom line. ...read more


Data: friend, foe or both? How life sciences leaders can benefit from data proliferation

Written by Watson Health | Data, Life Sciences

Companies could benefit from using the wealth of intelligence to optimize the product development and commercialization process, if they can quickly access information when and where it’s needed most. ...read more


Maximize your drug’s potential with data

Written by Watson Health | Data, Life Sciences

From the earliest stages of discovery through treatment delivery, analytics and insights have the potential to inform and enhance every stage of the drug development and commercialization process. ...read more


Clinical trials don’t fail fast enough

Written by Watson Health | Analytics, Data, Life Sciences

The roughly $2.6 billion spent on developing one new drug reflects the fully capitalized costs of studying compounds that ultimately fail to reach the market. ...read more


Applauding Interoperability Improvements

Written by Anil Jain | Cloud, Data, Life Sciences

At IBM, we strongly believe that all citizens have a right to improved information flow between the various clinicians they see. ...read more


Making the Promise of Smarter Health a Reality

Written by Dr. John E. Kelly III | Analytics, Artificial intelligence, Cloud...

The true value of data flowing through physicians' offices and public health departments has gone untapped because it is unstructured and siloed in systems that don’t talk to one another. ...read more


Telehealth emerges as critical weapon for public health officials combating the opioid epidemic

Written by Peggy O'Brien | Analytics, Government, Life Sciences

This past October, the U.S. passed a package of bills focused on confronting the nation’s opioid epidemic. Collectively known as the SUPPORT for Patients and Communities Act[1], the legislation contains a number of legal and regulatory tweaks designed to make addiction treatment more accessible. Among them is a new focus on telehealth, which will make ...read more


From automated to comprehensive: What child welfare organizations need to succeed

Written by Watson Health | Government, Life Sciences

Of all the programs and services regulated, administered or delivered by government, there are arguably none more important than the delivery of child welfare services: child protection, foster care and adoption. ...read more


Success story: The Aurum Institute

Written by Watson Health | Life Sciences, Stories

The Aurum Institute needed to integrate clinical data from cross-border research sites located in several sub-Saharan African countries, each run by data managers who speak different languages and possess varied levels of experience with electronic data capture. ...read more


“Connected health” designed for health

Written by Watson Health | Life Sciences

Over the years, the life sciences industry has been investing in capturing and analyzing patient health information. Specifically, companies have been creating digital health applications with the goal of improving treatment and care. ...read more


Discover “Discovery”

Written by Louisa Roberts | Artificial intelligence, Life Sciences, Provider

I have worked with various flavors of Watson in the last 4 years, and it has taught me a lot about the need to understand bias, both in data and the interpretation of it.  In the spirit of transparency, I will be honest about my own bias – my favorite Watson Health product is Watson ...read more


SmartAnalyst Inc. used IBM Explorys clinical data to improve how a company markets its medications

Written by Watson Health | Life Sciences, Stories

SmartAnalyst and the IBM® Watson Health™ team used the IBM Explorys® data set to study the journey of more than 6,500 real-life psoriasis patients. As a result, SmartAnalyst’s customer, a pharmaceutical company, is changing the way it communicates with patients and doctors. ...read more